Trials / Recruiting
RecruitingNCT06826534
At-Home Cardiac Rehabilitation for Adolescents at Risk for Heart Failure
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- Sponsor
- Children's Hospital Los Angeles · Academic / Other
- Sex
- All
- Age
- 0 Years – 21 Years
- Healthy volunteers
- Not accepted
Summary
The goal of this clinical trial is to explore the impact that an at-home cardio-oncology rehabilitation (CORE) may have on short-term cardiovascular fitness and psychosocial wellness in pediatric cancer survivors. The main question it aims to answer are * To evaluate the efficacy of an at-home CORE model on short-term cardiovascular fitness and psychosocial wellbeing in adolescent cancer survivors. * To evaluate the exercise adherence rate among adolescents at risk for heart failure and assess barriers to compliance. * To explore which specific CORE resources are of most value to patients in creating sustainable healthy lifestyle modifications. * Hypothesis: Pediatric cancer survivors who implement exercise and dietary recommendations will demonstrate improvement in cardiovascular fitness and general wellness. A multidisciplinary team approach can facilitate adherence to a moderately rigorous exercise prescription, and thus enhance the health benefits of a CORE program at CHLA. Participants will undergo cardiovascular studies and a quality-of-life survey prior to exercise intervention, and at the end of the 6-month study period.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Cardio-oncology rehabilitation | Least 60 minutes of physical activity each day including vigorous-intensity and strengthening activities at least 3 days per week |
Timeline
- Start date
- 2023-10-20
- Primary completion
- 2025-12-31
- Completion
- 2025-12-31
- First posted
- 2025-02-14
- Last updated
- 2025-02-14
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT06826534. Inclusion in this directory is not an endorsement.